2017
DOI: 10.1177/2045125317737003
|View full text |Cite
|
Sign up to set email alerts
|

When the drugs don’t work: treatment-resistant schizophrenia, serotonin and serendipity

Abstract: Treatment-resistant schizophrenia is a serious clinical problem. We adopt a systems-level approach positing a greater role for cognitive control mechanisms in the development of psychotic symptoms and illustrate the clinical application of this via a case report of treatment-resistant patients treated successfully with adjunct pro-cognitive serotonergic medication.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 22 publications
(13 citation statements)
references
References 25 publications
0
12
0
1
Order By: Relevance
“…However, our findings suggest that cognitive control could be an important avenue for novel interventional approaches to the treatment of persistent positive symptoms and prevention of chronic illness. Preliminary work using psychological approaches, neuromodulation and pro-cognitive psychopharmacology ( Cella et al, 2020 , Lowe et al, 2018 , Orlov et al, 2017 ) demonstrate some promise.…”
Section: Discussionmentioning
confidence: 99%
“…However, our findings suggest that cognitive control could be an important avenue for novel interventional approaches to the treatment of persistent positive symptoms and prevention of chronic illness. Preliminary work using psychological approaches, neuromodulation and pro-cognitive psychopharmacology ( Cella et al, 2020 , Lowe et al, 2018 , Orlov et al, 2017 ) demonstrate some promise.…”
Section: Discussionmentioning
confidence: 99%
“…Instead, self-inhibitory connectivity within the ACC was increased in resistant patients, and ACC-striatal ‘hyper’-drive was associated with both increased psychotic symptoms and aberrant salience. This suggests that ACC function may be inefficient in resistant patients and that symptoms may persist if top-down regulation of the reward network is impaired – a mechanism that is not targeted by current antipsychotic medication ( Lowe et al, 2018 ). The specificity of this finding would be best addressed using a prospective longitudinal design, with larger numbers of patients, to test the potential of these effective connectivity measures to predict treatment resistance.…”
Section: Discussionmentioning
confidence: 99%
“…The pattern of decreased striatal activation and increased prefrontal activation supports the suggestion that the evolution of clinically relevant psychotic symptoms requires not only a deficit in striatal reward processing, but also a putative failure of compensatory frontal executive processes. 24,25 Thus, this increase in right frontal activation in PLEs may serve as a proxy of executive function-a compensatory mechanism to ensure that any unusual experiences secondary to reward processing deficits do not become incorrectly represented given the current context. The lack of any neuropsychological performance differences in executive functioning between the low and high PLE adolescent groups also lends additional support to this view.…”
Section: Discussionmentioning
confidence: 99%